Pharmabiz

Lupin establishes a new global standard in sustainable pharma with an S&P Global ESG Score of 91

Lupin establishes a new global standard in sustainable pharma with an S&P Global ESG Score of 91: Our Bureau, Bengaluru Friday, November 14, 2025, 16:30 Hrs [IST] Lupin has achiev ...
Pharmabiz

Metropolis data reveals 1 in 3 Indians show early signs of metabolic syndrome, urges early screening beyond blood sugar checks

Metropolis data reveals 1 in 3 Indians show early signs of metabolic syndrome, urges early screening beyond blood sugar checks: Our Bureau, Bengaluru Friday, November 14, 2025, 16 ...
Pharmabiz

EirGenix inks licensing agreement with Sandoz AG for commercialization of its independently developed breast cancer biosimilar, EG1206A

EirGenix inks licensing agreement with Sandoz AG for commercialization of its independently developed breast cancer biosimilar, EG1206A: Taipei Friday, November 14, 2025, 16:00 Hr ...
Pharmabiz

Kotak Alts invests Rs. 400 million in Mediversal Healthcare

Kotak Alternate Asset Managers through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs. 400 million in ...